{"id":"W1926565992","doi":"10.3978/j.issn.2078-6891.2014.019","title":"Outcomes of patients treated with capecitabine and temozolamide for advanced pancreatic neuroendocrine tumors (PNETs) and non-PNETs.","year":2014,"lang":"en","type":"article","venue":"PubMed","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Capecitabine; Neuroendocrine tumors; Internal medicine; Hazard ratio; Gastroenterology; Chemotherapy; Cohort; Retrospective cohort study; Pancreas; Progression-free survival; Cancer; Rectum; Oncology; Colorectal cancer; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000240124,0.0001572544,0.0003481196,0.0002770519,0.0002951237,0.0003622541,0.000164807,0.0002499319,0.0007900922],"category_scores_gemma":[0.0007876588,0.00008624531,0.0003889244,0.0004151559,0.0002129493,0.0002642389,0.0002927266,0.0003389276,0.0001124725],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000761221,"about_ca_system_score_gemma":0.0004061204,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002176597,"about_ca_topic_score_gemma":0.00370211,"domain_scores_codex":[0.9998664,0.00002104422,0.0000161536,0.00003331904,0.00002257926,0.00004047313],"domain_scores_gemma":[0.9993536,0.0000831666,0.0003122594,0.000014846,0.00003209827,0.000204157],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001266596,0.00008511772,0.9920505,0.00002623845,0.00005448043,0.0008303096,0.00008809579,0.0002337647,0.0005088521,0.00001708675,0.0001538786,0.004685059],"study_design_scores_gemma":[0.0001208709,0.002097407,0.9932281,0.0000139657,0.00007058291,0.003186696,0.0001654849,0.0004200617,0.0002464236,0.00004562589,0.0003989831,0.000005719186],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9991425,0.0003424321,0.00002491801,0.00003117949,0.00000383802,0.000008723076,0.0001780056,0.000001525192,0.0002668341],"genre_scores_gemma":[0.9992337,0.0001303817,0.00003096877,0.00002504833,0.000007737566,0.000008212132,0.000486796,7.405707e-7,0.00007639296],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002176597,"threshold_uncertainty_score":0.005523086,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009728381181289315,"score_gpt":0.2446690522949328,"score_spread":0.2349406711136435,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}